DOCK8 in immune cells: roles and mechanisms

Engineering notes

Key topics: autonomous driving, control. See the paper for implementation details and experimental results.

Chinese explanation / 中文解读

中文解读待补充：本站会优先为端到端自动驾驶、BEV感知、3D目标检测、轨迹预测、路径规划、LiDAR感知等高价值论文补充中文说明。

Original abstract

DOCK8 (dedicator of cytokinesis 8) is a prominent member of the DOCK−C subfamily and functions as an atypical guanine nucleotide exchange factor (GEF). It primarily activates Rho family small GTPases—most notably Cdc42—to orchestrate cytoskeletal remodeling, and it integrates multiple key signaling pathways to preserve the functional integrity of immune cells. Recent work has established DOCK8 as a central player in both innate and adaptive immunity. In T cells, DOCK8 contributes to migration, immunological synapse assembly, lineage specification, and long−term survival, thereby supporting antiviral defense and immune homeostasis. In B cells, it fine−tunes BCR signaling, amplifies CD19−driven signals, coordinates metabolic reprogramming, and facilitates germinal center reactions, all of which underpin humoral immunity and immunological memory. In NK cells, DOCK8 influences cytotoxic activity and tissue localization by modulating immunological synapse architecture and proximal receptor signaling. In dendritic cells and macrophages, it helps regulate chemotactic migration and immune activation by precisely controlling Cdc42 activity and cytoskeletal dynamics. Mechanistically, DOCK8 serves as a signaling hub that integrates inputs from the TCR, BCR, and Toll−like receptors, coordinating the establishment of cell polarity, directed migration, immunological synapse stability, and effector function. Deficiency of DOCK8 leads to a complex immunodeficiency syndrome characterized by impaired immune surveillance, heightened susceptibility to viral, bacterial, and fungal infections, as well as allergic manifestations and disrupted immune tolerance. Although considerable progress has been made in understanding DOCK8, the integrated mechanisms operating across different immune cell types and signaling networks still await systematic elucidation. Future investigations should focus on dissecting multi−tiered signaling networks and exploring targeted interventional strategies.

Links and sources

• PDF from original source

Comments